Toku Eyes brings its AI platform to the US, allowing for accurate identification of...
Called ORAiCLE, it can assess the cardiovascular risk of an individual through a retinal scan, more accurately than the current gold standard.
Aegis Ventures, Northwell Holdings launch Optain, a new company for detection and prevention of...
With an initial seed investment of $12 million, Optain becomes the first company announced in Ascertain's growing portfolio of AI companies.